Non-steroidal LXR agonists; an emerging therapeutic strategy for the treatment of atherosclerosis.

Recent patents on cardiovascular drug discovery

Volumn 1, Issue 1, 2006, Pages 21-46

  Bennett, David J ^a   Cooke, Andrew J ^a   Edwards, Andrew S ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; ACETYL COENZYME A CARBOXYLASE; CELL RECEPTOR; DNA BINDING PROTEIN; FATTY ACID SYNTHASE; LIVER X RECEPTOR; N (2,2,2 TRIFLUOROETHYL) N [4 [2,2,2 TRIFLUORO 1 HYDROXY 1 (TRIFLUOROMETHOXY)ETHYL]PHENYL]BENZENESULFONAMIDE; OSTEOPONTIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; SULFONAMIDE; THROMBOPLASTIN;

ANIMAL; ATHEROSCLEROSIS; DRUG POTENTIATION; GENETICS; HUMAN; REVIEW;

ACETYL-COA CARBOXYLASE; ANIMALS; ATHEROSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; DNA-BINDING PROTEINS; FATTY ACID SYNTHETASE COMPLEX; HUMANS; OSTEOPONTIN; RECEPTORS, CYTOPLASMIC AND NUCLEAR; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; SULFONAMIDES; THROMBOPLASTIN;

EID: 35148847350     PISSN: 15748901     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489006775244245     Document Type: Review

References (127)